Cargando…

Nanomedicine and versatile therapies for cancer treatment

The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shukla, Aparna, Maiti, Pralay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386439/
https://www.ncbi.nlm.nih.gov/pubmed/35992969
http://dx.doi.org/10.1002/mco2.163
_version_ 1784769811157352448
author Shukla, Aparna
Maiti, Pralay
author_facet Shukla, Aparna
Maiti, Pralay
author_sort Shukla, Aparna
collection PubMed
description The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional therapies. In this review, different nanocarriers for controlled drug release and their routes of administration have been discussed in detail, especially for cancer treatment. Special emphasis has been given on the design of drug delivery vehicles for sustained release and specific application methods for targeted delivery to the affected areas. Different polymeric vehicles designed for the delivery of chemotherapeutics have been discussed, including graft copolymers, liposomes, hydrogels, dendrimers, micelles, and nanoparticles. Furthermore, the effect of dimensional properties on chemotherapy is vividly described. Another integral section of the review focuses on the modes of administration of nanomedicines and emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, for cancer treatment. The properties, therapeutic value, advantages, and limitations of these nanomedicines are highlighted, with a focus on their increased performance versus conventional molecular anticancer therapies.
format Online
Article
Text
id pubmed-9386439
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93864392022-08-19 Nanomedicine and versatile therapies for cancer treatment Shukla, Aparna Maiti, Pralay MedComm (2020) Reviews The higher prevalence of cancer is related to high rates of mortality and morbidity worldwide. By virtue of the properties of matter at the nanoscale, nanomedicine is proven to be a powerful tool to develop innovative drug carriers with greater efficacies and fewer side effects than conventional therapies. In this review, different nanocarriers for controlled drug release and their routes of administration have been discussed in detail, especially for cancer treatment. Special emphasis has been given on the design of drug delivery vehicles for sustained release and specific application methods for targeted delivery to the affected areas. Different polymeric vehicles designed for the delivery of chemotherapeutics have been discussed, including graft copolymers, liposomes, hydrogels, dendrimers, micelles, and nanoparticles. Furthermore, the effect of dimensional properties on chemotherapy is vividly described. Another integral section of the review focuses on the modes of administration of nanomedicines and emerging therapies, such as photothermal, photodynamic, immunotherapy, chemodynamic, and gas therapy, for cancer treatment. The properties, therapeutic value, advantages, and limitations of these nanomedicines are highlighted, with a focus on their increased performance versus conventional molecular anticancer therapies. John Wiley and Sons Inc. 2022-08-18 /pmc/articles/PMC9386439/ /pubmed/35992969 http://dx.doi.org/10.1002/mco2.163 Text en © 2022 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Shukla, Aparna
Maiti, Pralay
Nanomedicine and versatile therapies for cancer treatment
title Nanomedicine and versatile therapies for cancer treatment
title_full Nanomedicine and versatile therapies for cancer treatment
title_fullStr Nanomedicine and versatile therapies for cancer treatment
title_full_unstemmed Nanomedicine and versatile therapies for cancer treatment
title_short Nanomedicine and versatile therapies for cancer treatment
title_sort nanomedicine and versatile therapies for cancer treatment
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386439/
https://www.ncbi.nlm.nih.gov/pubmed/35992969
http://dx.doi.org/10.1002/mco2.163
work_keys_str_mv AT shuklaaparna nanomedicineandversatiletherapiesforcancertreatment
AT maitipralay nanomedicineandversatiletherapiesforcancertreatment